Safety and Efficacy of INGAP-Peptide in Patients With Type 2 Diabetes

• Status: Completed
• Trial end date: 2004-06-01
• Target enrollment: 0
• Participant gender: All

Summary

Insulin is a chemical that the body needs in order to use or store sugar. It is made by a type of cell called a beta cell which resides in an organ known as the pancreas. Type 2 diabetes is a disease where the beta cells are unable to meet a person's insulin needs. Sugar levels rise in the blood as a result. INGAP-Peptide is being tested to attempt to create new beta cells in the pancreas, and to improve the ability to produce insulin in type 2 diabetic patients.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Exsulin Corporation

Criteria

Inclusion Criteria

• Age 35-70

• Using >20 Units of insulin per day

• HbA1c from 6.5% to 10%

• No islet antibodies

• Otherwise healthy